AI assistant
CVS HEALTH Corp — Director's Dealing 2017
Jun 28, 2017
29875_dirs_2017-06-28_5d251945-47c3-45fd-ab87-4821634f5065.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2017-06-26
Reporting Person: Foulkes Helena (EVP, President-CVS Pharmacy)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-06-26 | Common Stock | M | 14304 | $34.96 | Acquired | 59300.6533 | Direct |
| 2017-06-26 | Common Stock | M | 6029 | $34.96 | Acquired | 65329.6533 | Direct |
| 2017-06-26 | Common Stock | S | 20333 | $80.00 | Disposed | 44996.6533 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-06-26 | Stock Option | $34.96 | M | 14304 | Disposed | 2021-04-01 | Common Stock (14304) | Direct |
| 2017-06-26 | Stock Option | $34.96 | M | 6029 | Disposed | 2018-04-01 | Common Stock (6029) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (restricted) | 51191 | Direct |
| ESOP Common Stock | 4071.4622 | Indirect |
| Stock Unit | 55594.6176 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $45.07 | 2019-04-02 | Common Stock (19965) | 19965 | Direct |
| Stock Option | $54.53 | 2020-04-01 | Common Stock (39340) | 39340 | Direct |
| Stock Option | $74.29 | 2021-04-01 | Common Stock (52452) | 52452 | Direct |
| Stock Option | $102.26 | 2022-04-01 | Common Stock (59922) | 59922 | Direct |
| Stock Option | $104.82 | 2023-04-01 | Common Stock (71696) | 71696 | Direct |
| Stock Option | $78.05 | 2024-04-03 | Common Stock (150268) | 150268 | Direct |
Footnotes
F1: All sales were effected pursuant to a Rule 10b5-1 plan.
F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $80.00 and $80.02 per share.
F3: Option became exercisable in three equal annual installments, commencing 4/1/2014.
F4: Option became exercisable in four equal annual installments, commencing 4/1/2012.
F5: Option became exercisable in four equal annual installments, commencing 4/2/2013.
F6: Option became exercisable in four equal annual installments, commencing 4/1/2014.
F7: Option became exercisable in four equal annual installments, commencing 4/1/2015.
F8: Option became exercisable in four equal annual installments, commencing 4/1/2016.
F9: Option became exercisable in four equal annual installments, commencing 4/1/2017.
F10: Option becomes exercisable in four equal annual installments, commencing 4/3/2018.